Sieper Joachim
Medical Department I, Rheumatology, Charitè, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.
Curr Rheumatol Rep. 2004 Apr;6(2):110-6. doi: 10.1007/s11926-004-0055-7.
Reactive arthritis (ReA) occurs after a preceding bacterial infection of the urogenital or gastroenteral tract. The bacteria triggering ReA persist in vivo and seem to be responsible for triggering an immune response. A cytokine imbalance with a relative lack of T-helper 1 cytokines may play an important role allowing these bacteria to survive. This seems to be relevant for manifestation and chronicity of the arthritis. For the chronic cases and cases evolving into ankylosing spondylitis, the interaction between bacteria and human leukocyte antigen B27 plays an additional crucial role. Among others, the arthritogenic peptide hypothesis is one way to explain this association. Human leukocyte antigen B27-restricted peptides from Yersinia and Chlamydia, which are stimulatory for CD8+ T cells derived from patients with ReA, have been identified. The exact role of such peptides for the pathogenesis of ReA and other spondyloarthritides still has to be defined.
反应性关节炎(ReA)发生于泌尿生殖道或胃肠道先前的细菌感染之后。引发ReA的细菌在体内持续存在,似乎是引发免疫反应的原因。相对缺乏辅助性T细胞1细胞因子的细胞因子失衡可能在使这些细菌存活方面发挥重要作用。这似乎与关节炎的表现和慢性化有关。对于慢性病例以及发展为强直性脊柱炎的病例,细菌与人类白细胞抗原B27之间的相互作用起着额外的关键作用。其中,致关节炎肽假说是解释这种关联的一种方式。已经鉴定出耶尔森菌和衣原体来源的、对ReA患者来源的CD8 + T细胞具有刺激作用的人类白细胞抗原B27限制性肽。此类肽在ReA和其他脊柱关节炎发病机制中的确切作用仍有待确定。